Sol-Gel Technologies (SLGL) entered into a product purchase agreement with a subsidiary of Mayne Pharma Group (MAYNF) for the sale and ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Ironwood Pharma (IRWD – Research Report) today. The company’s shares closed last Friday at $0.95. Discover outperforming ...

Tariffs on pharmaceuticals would go against a duty-free agreement that the U.S. signed on to under the World Trade Organization, which barely held up during Trump’s first term. Under the 1994 ...

April 17 (Reuters) - Australian oil and gas producer Santos (STO.AX), opens new tab posted a 7% fall in first-quarter sales revenue on Thursday, hurt by lower crude sales volumes and weak realised ...

A Russian missile struck a warehouse belonging to Kusum Healthcare, an Indian pharmaceutical company, in Ukraine, prompting condemnation from the Ukrainian embassy, which alleged a deliberate ...

Given the extent of India’s pharma exports to US, this has created a certain bit of uncertainty in the market. Trump said the US would impose tariffs on autos, pharmaceuticals and aluminum in ...

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

During a meeting with his cabinet Monday, President Donald Trump said that tariffs on pharmaceuticals would begin in the "not too distant" future. The president didn't provide specifics on whether ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...